{"id":"NCT03511664","sponsor":"Endocyte","briefTitle":"Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer","officialTitle":"VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-05-29","primaryCompletion":"2021-01-27","completion":"2023-12-14","firstPosted":"2018-04-30","resultsPosted":"2022-05-09","lastUpdate":"2025-01-13"},"enrollment":861,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"177Lu-PSMA-617","otherNames":[]},{"type":"OTHER","name":"Best supportive/best standard of care","otherNames":[]}],"arms":[{"label":"177Lu-PSMA-617 plus best supportive/best standard of care (BS/BSOC)","type":"EXPERIMENTAL"},{"label":"Best supportive/best standard of care (BS/BSOC) alone","type":"OTHER"}],"summary":"The primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with progressive prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who received 177Lu-PSMA-617 in addition to best supportive/best standard of care (BSC/BSoC) versus patients treated with best supportive/best standard of care alone.","primaryOutcome":{"measure":"Radiographic Progression-free Survival (rPFS)","timeFrame":"From date of randomization until date of radiographic progression or date of death from any cause, whichever comes first, assessed up to 32 months (Primary Analysis cut-off date = 27-Jan-2021)","effectByArm":[{"arm":"Main Study: 177Lu-PSMA-617 Plus Best Supportive/Best Standard of Care (BS/BSOC)","deltaMin":8.7,"sd":null},{"arm":"Main Study: Best Supportive/Best Standard of Care (BS/BSOC) Alone","deltaMin":3.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":88,"countries":["United States","Belgium","Canada","Denmark","France","Germany","Netherlands","Puerto Rico","Sweden","United Kingdom"]},"refs":{"pmids":["31595044","38534939","37269841","38050121","37230533","34161051","39242323","38185538","39430616","39162634","39031642","33189510"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":195,"n":529},"commonTop":["Fatigue","Nausea","Dry mouth","Anaemia","Back pain"]}}